MedTrace Logo

Prebiotic and Anti-inflammatory Effects of a Pectin Polysaccharide

NCT05421793 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2023-09-21

No results posted yet for this study

Summary

The aim of this study is to determine, quantify and understand the potential prebiotic and anti-inflammatory effects of the pecticpolysaccharide rhamnogalacturonan I (RG-I). The effects of these dietary fibre fractions on barrier function will also be investigated.

Conditions

  • Healthy

Interventions

OTHER

Fermented product of carrot derived rhamnogalacturonan I

Stimulation of human colonic biopsies with the fermented product of carrot derived rhamnogalacturonan I

Sponsors & Collaborators

  • NutriLeads B.V. (Wageningen, The Netherlands)

    collaborator UNKNOWN

  • Örebro University, Sweden

    lead OTHER

Principal Investigators

  • Robert Brummer, Professor · Örebro University, School of Medical Sciences, Sweden

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-06
Primary Completion
2023-07-30
Completion
2023-08-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05421793 on ClinicalTrials.gov